BRIDGE Webinar: From Contractors to Co-creators
Cell and gene therapies have demonstrated clear clinical potential—but the key question remains: can they be delivered at scale? As the field moves from scientific breakthroughs toward industrial reality, manufacturing is no longer a late-stage step in development, but a critical determinant of success. With therapies increasingly advancing toward more standardized, off-the-shelf models, the traditional separation between science and manufacturing is being fundamentally challenged.
In this webinar, Luisa Lundin from NorthX will share insights on how CDMOs are evolving from being service providers to becoming early, integrated partners in development. The discussion will focus on how this shift impacts scalability, development strategies, and the path from promising science to reliable patient impact—and when manufacturing should become a central part of the conversation.Date: May 12
ABOUT BRIDGE
Running for 3 years and supported by SweLife through the Swedish Innovation Agency, Vinnova, BRIDGE aims to create a development platform spanning from identifying drug candidates to production. Project start: 2024.
PROJECT PARTNERS
Testa Center (Project Coordinator): A national “open access” laboratory and production environment for academics and companies looking to verify and upscale their biological process for large-scale production.
SciLifeLab Drug Discovery and Development Platform (DDD): A national research infrastructure providing state-of-the-art technology and expertise in drug development, from small molecules, biological pharmaceuticals, therapeutic oligonucleotides, and new modalities, from concept to preclinical stage.
Stem Cell Center & Pre-GMP Lund University (LU): Conducting research in cell, tissue, and gene therapy, and supporting researchers with pre-GMP services to bridge the gap from research findings to patient care. These units also closely collaborate with the ATMP center (SUS), a node for Region Skåne’s work with ATMP treatments.
STUNS: Foundation for collaboration between universities in Uppsala, industry, and society, promoting co-creation at the intersection of universities, industry, and society to create new opportunities.
ALIS (Association of Life Science Incubators): A national platform that brings together nine regional life science incubators (GU Ventures, KI Innovations, Lead, Medeon, Sahlgrenska Science Park, Smile Incubator, STING, Umeå Biotech Incubator och Uppsala Innovation Center) tasked with supporting and guiding startups and research groups in skills development, business development, coaching, and access to national and international private capital